Spruce Biosciences, Inc.(SPRB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SPRB Spruce Biosciences, Inc.

未开盘 12-20 16:00:00 EST

0.4000

+0.0179

+4.68%

盘后0.3994

-0.0006-0.15%

18:00 EST

最高0.4000	最低0.3740	成交量34.71万
今开0.3817	昨收0.3821	日振幅6.80%
总市值1,652万	流通市值869.97万	总股本4,130万
成交额13.29万	换手率1.60%	流通股本2,175万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"SPRB","market":"US","secType":"STK","nameCN":"Spruce Biosciences, Inc.","latestPrice":0.4,"timestamp":1734728400000,"preClose":0.3821,"halted":0,"volume":347129,"hourTrading":{"tag":"盘后","latestPrice":0.3994,"preClose":0.4,"latestTime":"18:00 EST","volume":26391,"amount":10554.44,"timestamp":1734735603671},"delay":0,"floatShares":21749234,"shares":41302599,"eps":-0.959594,"marketStatus":"未开盘","marketStatusCode":0,"change":0.0179,"latestTime":"12-20 16:00:00 EST","open":0.3817,"high":0.4,"low":0.374,"amount":132935.515166,"amplitude":0.068045,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.959594,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1734944400000},"adr":0,"listingDate":1602216000000,"adjPreClose":0.3821,"preHourTrading":{"tag":"盘前","latestPrice":0.382,"preClose":0.3821,"latestTime":"09:11 EST","volume":6203,"amount":2314.606339,"timestamp":1734703900029},"postHourTrading":{"tag":"盘后","latestPrice":0.3994,"preClose":0.4,"latestTime":"18:00 EST","volume":26391,"amount":10554.44,"timestamp":1734735603671},"volumeRatio":0.7111122128940217,"impliedVol":2.1296,"impliedVolPercentile":0.8702},"requestUrl":"/m/hq/s/SPRB/wiki","defaultTab":"wiki","newsList":[{"id":"2492715661","title":"Spruce Biosciences, Inc.盘中异动 下午盘股价大跌5.76%报0.381美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492715661","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492715661?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:28","pubTimestamp":1734553717,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时28分，Spruce Biosciences, Inc.股票出现异动，股价快速下挫5.76%。截至发稿，该股报0.381美元/股，成交量48.8453万股，换手率1.18%，振幅8.48%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为2.38%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219042837ab829aeb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219042837ab829aeb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRB"],"gpt_icon":0},{"id":"2492875992","title":"Spruce Biosciences, Inc.盘中异动 下午盘大幅上涨5.48%报0.410美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492875992","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492875992?lang=zh_cn&edition=full","pubTime":"2024-12-18 03:42","pubTimestamp":1734464523,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日03时42分，Spruce Biosciences, Inc.股票出现异动，股价急速拉升5.48%。截至发稿，该股报0.410美元/股，成交量50.0726万股，换手率1.21%，振幅5.48%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.74%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218034203ab7fd8c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218034203ab7fd8c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRB"],"gpt_icon":0},{"id":"2490863794","title":"Spruce Biosciences, Inc.盘中异动 股价大跌23.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490863794","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490863794?lang=zh_cn&edition=full","pubTime":"2024-12-11 22:32","pubTimestamp":1733927521,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日22时32分，Spruce Biosciences, Inc.股票出现波动，股价快速跳水23.24%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Candel Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Silexion Therapeutics Corp、Candel Therapeutics, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为367.15%、106.81%、97.36%，振幅较大的相关个股有Candel Therapeutics, Inc.、Cardio Diagnostics Holdings Inc.、Tnf Pharmaceuticals, Inc.，振幅分别为19.09%、18.52%、18.15%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211223201a1e66adb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211223201a1e66adb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRB"],"gpt_icon":0},{"id":"2490027984","title":"BUZZ-斯普鲁斯生物公司削减遗传性疾病药物投资后股价下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2490027984","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490027984?lang=zh_cn&edition=full","pubTime":"2024-12-11 06:26","pubTimestamp":1733869598,"startTime":"0","endTime":"0","summary":"** CAH是一种罕见的遗传病，会影响人体产生和调节关键激素的能力 ** 增加了对战略机遇和成本削减活动的评估 ** 截至上一交易日收盘，股价累计下跌约 82(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241210:nL4T3NB1UC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2490029855","title":"斯普鲁斯生物科学公司将停止对遗传性疾病药物的投资","url":"https://stock-news.laohu8.com/highlight/detail?id=2490029855","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490029855?lang=zh_cn&edition=full","pubTime":"2024-12-11 05:11","pubTimestamp":1733865082,"startTime":"0","endTime":"0","summary":"斯普鲁斯生物科学公司将停止对遗传性疾病药物的投资路透12月10日 - 斯普鲁斯生物科学公司（Spruce Biosciences SPRB.O）周二表示，由于在一项中期研究中未能达到主要目标，该公司将停止对其遗传性疾病药物的投资。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241210:nL4S3NB1OR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRB"],"gpt_icon":0},{"id":"2489239218","title":"Spruce Biosciences, Inc.盘中异动 早盘大幅上涨5.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489239218","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489239218?lang=zh_cn&edition=full","pubTime":"2024-12-06 22:45","pubTimestamp":1733496318,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日22时45分，Spruce Biosciences, Inc.股票出现异动，股价大幅拉升5.98%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。其相关个股中，Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Immatics N V C/Wts 01/07/2025 、Dermata Therapeutics Inc C/Wts 涨幅较大，Molecular Templates, Inc.、Psyence Biomedical Ltd.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为33.63%、28.33%、16.04%，振幅较大的相关个股有Cardio Diagnostics Holdings Inc.、Aileron Therapeutics, Inc.、Renovaro Inc.，振幅分别为18.09%、17.24%、15.97%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206224518971c2565&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206224518971c2565&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRB"],"gpt_icon":0},{"id":"2489497378","title":"Spruce Biosciences, Inc.盘中异动 下午盘大幅跳水5.58%报0.491美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489497378","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489497378?lang=zh_cn&edition=full","pubTime":"2024-12-06 04:02","pubTimestamp":1733428936,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日04时02分，Spruce Biosciences, Inc.股票出现异动，股价急速跳水5.58%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Protara Therapeutics, Inc.、Molecular Templates, Inc.、Cardio Diagnostics Holdings Inc.涨幅较大，Molecular Templates, Inc.、Psyence Biomedical Ltd.、Protara Therapeutics, Inc.较为活跃，换手率分别为3681.23%、2355.87%、520.46%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Protara Therapeutics, Inc.、Molecular Templates, Inc.，振幅分别为136.00%、127.97%、124.83%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120604021698e5ab46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120604021698e5ab46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2488926215","title":"Spruce Biosciences, Inc.盘中异动 股价大跌8.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488926215","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488926215?lang=zh_cn&edition=full","pubTime":"2024-12-04 01:46","pubTimestamp":1733247972,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日01时46分，Spruce Biosciences, Inc.股票出现波动，股价大幅下挫8.03%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.81%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120401461298e52420&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120401461298e52420&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRB"],"gpt_icon":0},{"id":"2486605844","title":"Spruce Biosciences, Inc.盘中异动 股价大涨5.48%报0.510美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486605844","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486605844?lang=zh_cn&edition=full","pubTime":"2024-11-26 01:41","pubTimestamp":1732556510,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日01时41分，Spruce Biosciences, Inc.股票出现波动，股价大幅拉升5.48%。截至发稿，该股报0.510美元/股，成交量21.0952万股，换手率0.51%，振幅3.02%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.70%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112601415198e44788&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112601415198e44788&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2485126121","title":"Spruce Biosciences, Inc.盘中异动 早盘快速上涨5.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485126121","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485126121?lang=zh_cn&edition=full","pubTime":"2024-11-22 22:43","pubTimestamp":1732286630,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日22时43分，Spruce Biosciences, Inc.股票出现波动，股价急速上涨5.87%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。其相关个股中，Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Virpax Pharmaceuticals, Inc.、Exicure, Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Molecular Templates, Inc.较为活跃，换手率分别为898.74%、80.84%、69.04%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为44.82%、33.24%、30.69%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112222435098e442aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112222435098e442aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRB"],"gpt_icon":0},{"id":"2483309834","title":"Spruce Biosciences, Inc.盘中异动 大幅下挫5.18%报0.494美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483309834","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483309834?lang=zh_cn&edition=full","pubTime":"2024-11-15 23:59","pubTimestamp":1731686361,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日23时59分，Spruce Biosciences, Inc.股票出现异动，股价急速下挫5.18%。截至发稿，该股报0.494美元/股，成交量5.698万股，换手率0.14%，振幅3.03%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为3.45%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115235922abc512bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115235922abc512bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRB"],"gpt_icon":0},{"id":"2482367087","title":"斯普鲁斯生物科学公司（Spruce Biosciences Inc）报告截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2482367087","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482367087?lang=zh_cn&edition=full","pubTime":"2024-11-11 23:31","pubTimestamp":1731339095,"startTime":"0","endTime":"0","summary":"斯普鲁斯生物科学公司报告截至 9 月 30 日的季度业绩 - 收益摘要Spruce Biosciences Inc SPRB.OQ报告，截至9月30日的季度调整后每股亏损21美分，高于去年同期的每股-30美分。七位分析师对该季度的平均预期是每股亏损 24 美分。Spruce Biosciences Inc 公布的本季度每股收益为亏损 21 美分。Spruce Biosciences Inc 本季度股价上涨了 12.8%，今年迄今为止亏损了 81.7%。华尔街对 Spruce Biosciences Inc 的 12 个月目标价中位数为 2.50 美元。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241111:nL4T3MI13K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRB"],"gpt_icon":0},{"id":"2482073595","title":"Spruce Biosciences, Inc.盘中异动 早盘大幅下挫5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482073595","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482073595?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:49","pubTimestamp":1731336594,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时49分，Spruce Biosciences, Inc.股票出现异动，股价快速下跌5.02%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111224954971a5b90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111224954971a5b90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRB"],"gpt_icon":0},{"id":"2481483289","title":"Spruce Biosciences Inc 预计每股亏损24美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481483289","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481483289?lang=zh_cn&edition=full","pubTime":"2024-11-08 23:53","pubTimestamp":1731081235,"startTime":"0","endTime":"0","summary":"Spruce Biosciences Inc 预计每股亏损24美分 - 财报前瞻斯普鲁斯生物科学公司SPRB.OQ SPRB.O预计将在11月11日公布截至2024年9月30日的业绩报告时显示季度收入下降(估计)。LSEG 分析师对 Spruce Biosciences Inc 的平均预期是每股亏损 24 美分。华尔街对 Spruce Biosciences Inc 的 12 个月目标价中位数为 2.50 美元，高于上一次 0.55 美元的收盘价。11月8日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL4S3MF1TD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRB"],"gpt_icon":0},{"id":"2479035353","title":"Spruce Biosciences, Inc.盘中异动 大幅跳水5.37%报0.534美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479035353","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479035353?lang=zh_cn&edition=full","pubTime":"2024-10-31 22:04","pubTimestamp":1730383479,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日22时04分，Spruce Biosciences, Inc.股票出现波动，股价快速下跌5.37%。截至发稿，该股报0.534美元/股，成交量9.5668万股，换手率0.23%，振幅2.48%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为2.55%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103122043998e3fbc3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103122043998e3fbc3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRB"],"gpt_icon":0},{"id":"2478480469","title":"Spruce Biosciences, Inc.盘中异动 股价大涨5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478480469","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478480469?lang=zh_cn&edition=full","pubTime":"2024-10-28 23:09","pubTimestamp":1730128140,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日23时09分，Spruce Biosciences, Inc.股票出现波动，股价快速拉升5.53%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028230900a1f27fc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028230900a1f27fc8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRB"],"gpt_icon":0},{"id":"2478519726","title":"Spruce Biosciences, Inc.盘中异动 快速拉升5.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478519726","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478519726?lang=zh_cn&edition=full","pubTime":"2024-10-25 00:02","pubTimestamp":1729785767,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日00时02分，Spruce Biosciences, Inc.股票出现波动，股价大幅上涨5.70%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Viking Therapeutics, Inc.、Dbv Technologies涨幅较大，Qualigen Therapeutics, Inc.、Cns Pharmaceuticals, Inc.、Genprex, Inc.较为活跃，换手率分别为262.64%、181.19%、140.90%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Qualigen Therapeutics, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为77.83%、71.78%、60.32%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025000247ab70f117&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025000247ab70f117&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRB"],"gpt_icon":0},{"id":"2477967108","title":"Spruce Biosciences, Inc.盘中异动 快速上涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477967108","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477967108?lang=zh_cn&edition=full","pubTime":"2024-10-22 00:50","pubTimestamp":1729529436,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日00时50分，Spruce Biosciences, Inc.股票出现异动，股价急速拉升5.01%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.80%。其相关个股中，Genprex, Inc.、Biovie Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大，Genprex, Inc.、Gri Bio, Inc.、Biovie Inc.较为活跃，换手率分别为8061.09%、3386.65%、1525.48%，振幅较大的相关个股有Genprex, Inc.、Biovie Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为369.73%、157.02%、148.15%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022005036ab6bc4b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022005036ab6bc4b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2475914279","title":"Spruce Biosciences, Inc.盘中异动 股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475914279","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475914279?lang=zh_cn&edition=full","pubTime":"2024-10-16 23:11","pubTimestamp":1729091507,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日23时11分，Spruce Biosciences, Inc.股票出现异动，股价大幅拉升5.05%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.65%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101623114798e3ccfb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101623114798e3ccfb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRB"],"gpt_icon":0},{"id":"2475319797","title":"Spruce Biosciences, Inc.盘中异动 下午盘股价大涨5.09%报0.467美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475319797","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475319797?lang=zh_cn&edition=full","pubTime":"2024-10-15 02:33","pubTimestamp":1728930780,"startTime":"0","endTime":"0","summary":"北京时间2024年10月15日02时33分，Spruce Biosciences, Inc.股票出现异动，股价快速上涨5.09%。截至发稿，该股报0.467美元/股，成交量17.9316万股，换手率0.43%，振幅7.25%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.58%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015023300971a02a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015023300971a02a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRB"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sprucebiosciences.com","stockEarnings":[{"period":"1week","weight":0.0438},{"period":"1month","weight":-0.1837},{"period":"3month","weight":-0.0909},{"period":"6month","weight":-0.2195},{"period":"1year","weight":-0.8049},{"period":"ytd","weight":-0.8635}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Spruce Biosciences, Inc.最初于2014年11月在特拉华州成立为一家有限责任公司。该公司是一家处于后期阶段的生物制药公司，专注于开发和商业化治疗罕见的内分泌疾病的新疗法，这些疾病的医疗需求尚未得到满足。该公司正在初步开发全资候选产品tildacerfont，作为潜在的第一个非甾体疗法，为患有典型先天性肾上腺增生症的患者提供显著改善的疾病控制和减少类固醇负担。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.33989},{"month":2,"riseRate":0.5,"avgChangeRate":0.009378},{"month":3,"riseRate":0,"avgChangeRate":-0.297383},{"month":4,"riseRate":0,"avgChangeRate":-0.078867},{"month":5,"riseRate":0.5,"avgChangeRate":-0.003763},{"month":6,"riseRate":0.25,"avgChangeRate":-0.126985},{"month":7,"riseRate":0.5,"avgChangeRate":-0.017508},{"month":8,"riseRate":0.25,"avgChangeRate":-0.021147},{"month":9,"riseRate":0.5,"avgChangeRate":-0.141116},{"month":10,"riseRate":0.25,"avgChangeRate":-0.193698},{"month":11,"riseRate":0.6,"avgChangeRate":0.019777},{"month":12,"riseRate":0.4,"avgChangeRate":0.279898}],"exchange":"NASDAQ","name":"Spruce Biosciences, Inc.","nameEN":"Spruce Biosciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Spruce Biosciences, Inc.(SPRB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Spruce Biosciences, Inc.(SPRB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Spruce Biosciences, Inc.,SPRB,Spruce Biosciences, Inc.股票,Spruce Biosciences, Inc.股票老虎,Spruce Biosciences, Inc.股票老虎国际,Spruce Biosciences, Inc.行情,Spruce Biosciences, Inc.股票行情,Spruce Biosciences, Inc.股价,Spruce Biosciences, Inc.股市,Spruce Biosciences, Inc.股票价格,Spruce Biosciences, Inc.股票交易,Spruce Biosciences, Inc.股票购买,Spruce Biosciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Spruce Biosciences, Inc.(SPRB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Spruce Biosciences, Inc.(SPRB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}